These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29441192)

  • 1. Knockdown of LncRNA MAPT-AS1 inhibites proliferation and migration and sensitizes cancer cells to paclitaxel by regulating MAPT expression in ER-negative breast cancers.
    Pan Y; Pan Y; Cheng Y; Yang F; Yao Z; Wang O
    Cell Biosci; 2018; 8():7. PubMed ID: 29441192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of lncRNA MAPT-AS1 exacerbates cell proliferation and metastasis in breast cancer.
    Li B; Liu D; Xu J; Lu Z; Liu Q; Zhao X; Wang X; Peng T; Xu J
    Transl Cancer Res; 2022 Apr; 11(4):835-847. PubMed ID: 35571636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of MAPT-AS1 is associated with better patient survival in breast cancer.
    Wang D; Li J; Cai F; Xu Z; Li L; Zhu H; Liu W; Xu Q; Cao J; Sun J; Tang J
    Biochem Cell Biol; 2019 Apr; 97(2):158-164. PubMed ID: 30074401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural antisense transcript HAS2-AS1 regulates breast cancer cells aggressiveness independently from hyaluronan metabolism.
    Parnigoni A; Caon I; Teo WX; Hua SH; Moretto P; Bartolini B; Viola M; Karousou E; Yip GW; Götte M; Heldin P; Passi A; Vigetti D
    Matrix Biol; 2022 May; 109():140-161. PubMed ID: 35395387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA heart and neural crest derivatives expressed 2-antisense RNA 1 overexpression inhibits the proliferation of cancer cells by reducing RUNX2 expression in triple-negative breast cancer.
    Wei M; Liu L; Wang Z
    Oncol Lett; 2019 Dec; 18(6):6775-6780. PubMed ID: 31788122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA FOXD3 antisense RNA 1 augments anti-estrogen resistance in breast cancer cells through the microRNA-363/ trefoil factor 1/ phosphatidylinositol 3-kinase/protein kinase B axis.
    Ren L; Zhou H; Lei L; Zhang Y; Cai H; Wang X
    Bioengineered; 2021 Dec; 12(1):5266-5278. PubMed ID: 34424807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA GNAS-AS1 facilitates ER+ breast cancer cells progression by promoting M2 macrophage polarization via regulating miR-433-3p/GATA3 axis.
    Liu SQ; Zhou ZY; Dong X; Guo L; Zhang KJ
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32538432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.
    Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C
    J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA CCND2-AS1 is up-regulated and regulates proliferation, migration, and invasion in breast cancer.
    Chen C; Xia E; Bhandari A; Wang Y; Shen Y; Sindan N; Lin Y; Wang X; Yang F; Wang O
    Int J Clin Exp Pathol; 2018; 11(3):1453-1459. PubMed ID: 31938243
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Mitobe Y; Ikeda K; Suzuki T; Takagi K; Kawabata H; Horie-Inoue K; Inoue S
    Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31501276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microtubule-associated protein tau (MAPT) is a promising independent prognostic marker and tumor suppressive protein in clear cell renal cell carcinoma.
    Han X; Sekino Y; Babasaki T; Goto K; Inoue S; Hayashi T; Teishima J; Sakamoto N; Sentani K; Oue N; Yasui W; Matsubara A
    Urol Oncol; 2020 Jun; 38(6):605.e9-605.e17. PubMed ID: 32139291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA.
    Luo N; Zhang K; Li X; Hu Y
    J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
    Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
    Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
    Zhou Y; Feng D; Gu X; Gao A; Liu Y
    Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
    Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
    Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
    Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
    Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
    Li GH; Yu JH; Yang B; Gong FC; Zhang KW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA MAFG-AS1 promotes proliferation and metastasis of breast cancer by modulating STC2 pathway.
    Di S; Bai R; Lu D; Chen C; Ma T; Zou Z; Zhang Z
    Cell Death Discov; 2022 May; 8(1):249. PubMed ID: 35513366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA TMPO-AS1 promotes progression of non-small cell lung cancer through regulating its natural antisense transcript TMPO.
    Qin Z; Zheng X; Fang Y
    Biochem Biophys Res Commun; 2019 Aug; 516(2):486-493. PubMed ID: 31230752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis.
    Han C; Fu Y; Zeng N; Yin J; Li Q
    Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.